CAMBRIDGE, England, January 6, 2015 /PRNewswire/ --
Crescendo Biologics, a company focused on the discovery and development of best-in-class Humabody™ human VH antibody fragment therapeutics, today announces its CEO Dr Mike Romanos will be presenting at the Biotech Showcase™ 2015 Conference being held in San Francisco, CA.
Details of Crescendo's presentation are as follows:
Date: Monday 12th January 2015
Time: 11:00 am
Track: A - Hearst (4th Floor)
Location: Parc 55 Wyndham San Francisco - Union Square Hotel
Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.
About Crescendo Biologics Ltd
Crescendo Biologics, based in Cambridge, UK, is focused on the discovery and development of best-in-class Humabody™ human VH antibody fragment therapeutics, using its novel transgenic platform. Crescendo is enabling the major VH product formats (multivalent, half-life-extended and topical) for its own pipeline, focused in inflammation and oncology, and to make it the partner of choice for human VH fragment therapeutics.
Citigate Dewe Rogerson
SOURCE Crescendo Biologics